38292023|t|Reduction of inflammation and mitochondrial degeneration in mutant SOD1 mice through inhibition of voltage-gated potassium channel Kv1.3.
38292023|a|Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no effective therapy, causing progressive loss of motor neurons in the spinal cord, brainstem, and motor cortex. Regardless of its genetic or sporadic origin, there is currently no cure for ALS or therapy that can reverse or control its progression. In the present study, taking advantage of a human superoxide dismutase-1 mutant (hSOD1-G93A) mouse that recapitulates key pathological features of human ALS, we investigated the possible role of voltage-gated potassium channel Kv1.3 in disease progression. We found that chronic administration of the brain-penetrant Kv1.3 inhibitor, PAP-1 (40 mg/Kg), in early symptomatic mice (i) improves motor deficits and prolongs survival of diseased mice (ii) reduces astrocyte reactivity, microglial Kv1.3 expression, and serum pro-inflammatory soluble factors (iii) improves structural mitochondrial deficits in motor neuron mitochondria (iv) restores mitochondrial respiratory dysfunction. Taken together, these findings underscore the potential significance of Kv1.3 activity as a contributing factor to the metabolic disturbances observed in ALS. Consequently, targeting Kv1.3 presents a promising avenue for modulating disease progression, shedding new light on potential therapeutic strategies for ALS.
38292023	13	25	inflammation	Disease	MESH:D007249
38292023	30	56	mitochondrial degeneration	Disease	MESH:D028361
38292023	67	71	SOD1	Gene	20655
38292023	72	76	mice	Species	10090
38292023	131	136	Kv1.3	Gene	16491
38292023	138	167	Amyotrophic lateral sclerosis	Disease	MESH:D000690
38292023	169	172	ALS	Disease	MESH:D000690
38292023	185	210	neurodegenerative disease	Disease	MESH:D019636
38292023	406	409	ALS	Disease	MESH:D000690
38292023	510	515	human	Species	9606
38292023	516	538	superoxide dismutase-1	Gene	6647
38292023	547	552	hSOD1	Gene	6647
38292023	553	557	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:9606;CA#:257327
38292023	559	564	mouse	Species	10090
38292023	613	618	human	Species	9606
38292023	619	622	ALS	Disease	MESH:D000690
38292023	693	698	Kv1.3	Gene	16491
38292023	783	788	Kv1.3	Gene	3738
38292023	800	805	PAP-1	Chemical	-
38292023	839	843	mice	Species	10090
38292023	857	871	motor deficits	Disease	MESH:D009461
38292023	906	910	mice	Species	10090
38292023	957	962	Kv1.3	Gene	16491
38292023	989	1001	inflammatory	Disease	MESH:D007249
38292023	1044	1066	mitochondrial deficits	Disease	MESH:D028361
38292023	1110	1147	mitochondrial respiratory dysfunction	Disease	MESH:D028361
38292023	1221	1226	Kv1.3	Gene	16491
38292023	1303	1306	ALS	Disease	MESH:D000690
38292023	1332	1337	Kv1.3	Gene	3738
38292023	1461	1464	ALS	Disease	MESH:D000690
38292023	Association	MESH:D000690	6647
38292023	Association	MESH:D000690	16491
38292023	Association	MESH:D009461	3738
38292023	Association	MESH:D007249	16491
38292023	Association	MESH:D000690	3738
38292023	Association	MESH:D028361	16491

